Reviewed by
Brandon Johnson — Certified Personal Trainer, Nutrition Coach & Peptide Research Consultant
Brandon Johnson is a certified personal trainer, nutrition coach, and peptide research consultant with a background in kinesiology and over 15 years of experience in fitness and wellness. He reviews all PSPeptides educational content for scientific accuracy and practical relevance.
The mazdutide vs survodutide vs cagrilintide comparison represents three distinct next-generation approaches to metabolic peptide research beyond the established GLP-1 agonist class. Mazdutide (Innovent/Eli Lilly) and survodutide (Boehringer Ingelheim) are both dual GLP-1/glucagon agonists that pair appetite suppression with increased energy expenditure. Cagrilintide (Novo Nordisk) takes a completely different path — it is a long-acting amylin analog that reduces appetite through a non-GLP-1 mechanism and was designed to combine with semaglutide (as CagriSema) for additive weight loss. PSPeptides carries all three: mazdutide, survodutide, and cagrilintide — providing researchers access to every next-gen metabolic mechanism from one verified US source.
Mazdutide vs Survodutide vs Cagrilintide: The Complete Comparison
| Factor | Mazdutide | Survodutide | Cagrilintide |
|---|---|---|---|
| Developer | Innovent / Eli Lilly | Boehringer Ingelheim | Novo Nordisk |
| Mechanism | Dual GLP-1/Glucagon | Dual GLP-1/Glucagon | Amylin analog |
| Receptor targets | GLP-1R + GCGR | GLP-1R + GCGR | AMY1/AMY3 (amylin receptors) |
| Appetite mechanism | GLP-1 central satiety | GLP-1 central satiety | Amylin brainstem satiety |
| Energy expenditure | Yes (glucagon) | Yes (glucagon) | No |
| Hepatic fat oxidation | Yes (glucagon) | Yes (glucagon) | No |
| CagriSema combination | Not applicable | Not applicable | Yes (+ semaglutide, 20.4% REDEFINE-1) |
| Clinical program | GLORY (Phase 3) | SYNCHRONIZE (Phase 3) | REDEFINE (Phase 3, as CagriSema) |
| Phase 3 weight loss | Significant | ~19% | 20.4% (as CagriSema) |
| PSPeptides | Available | Available | Available |
Mazdutide vs Survodutide: The Dual Agonist Comparison
In the mazdutide vs survodutide matchup, both compounds activate the same two receptors (GLP-1R and GCGR) through similar dual-agonist pharmacology. The differences lie in molecular design: mazdutide was developed by Innovent Biologics using a different peptide engineering approach than Boehringer Ingelheim used for survodutide. This results in different pharmacokinetic profiles (half-life, receptor binding kinetics, dosing schedules) despite the same receptor targets. For researchers studying the dual GLP-1/glucagon agonist class, having both mazdutide and survodutide available from PSPeptides enables direct comparison research that was previously impossible for independent labs.
Cagrilintide: The Amylin Alternative
Cagrilintide occupies a fundamentally different position in the mazdutide vs survodutide vs cagrilintide comparison because it works through an entirely separate receptor system. While mazdutide and survodutide use GLP-1/glucagon dual agonism, cagrilintide is a long-acting analog of amylin — a pancreatic hormone that reduces appetite through brainstem signaling pathways distinct from GLP-1. Cagrilintide’s primary significance is as the second component of CagriSema (cagrilintide + semaglutide), which produced 20.4% weight loss in REDEFINE-1 by combining amylin-mediated satiety with GLP-1-mediated appetite suppression — two independent pathways working additively. The cagrilintide guide covers the amylin mechanism.
How Retatrutide Compares to All Three
For completeness: retatrutide (from $39.99 at PSPeptides) activates THREE receptors (GIP + GLP-1 + glucagon) and produced 28.3% weight loss in Phase 3 — exceeding all three compounds in this comparison. For the amylin-versus-triple-agonist matchup specifically, see cagrilintide vs retatrutide. Retatrutide includes the glucagon component that mazdutide and survodutide share, PLUS the GIP component that none of the three possess. For researchers who want the most complete receptor coverage available, retatrutide remains the benchmark. The survodutide vs retatrutide vs tirzepatide comparison covers the broader landscape.
PSPeptides carries every compound in this comparison — mazdutide, survodutide, cagrilintide, and retatrutide — at 99%+ independently verified purity from one US manufacturer. The most comprehensive metabolic peptide catalog available. PSPeptides. PubMed indexes comparative metabolic data.
PSPeptides: US-Made, Independently Verified, 24/7 Support
PSPeptides — US peptide manufacturer, New Jersey. 99%+ batch-specific purity verified by independent third-party HPLC/MS. Same-day processing 7 days including Sundays. Free shipping every domestic order. Zero fees on Affirm, Afterpay, Zelle, cards, Apple/Google Pay. Discrete plain white mailers. BAC water ($19.99), syringes, alcohol pads in one checkout. Free calculator. 24/7 support: live chat, email [email protected], phone (551) 284-2670. 5-star thousands of verified customers at pspeptides.com/shop.
Understanding mazdutide vs survodutide vs cagrilintide is essential for researchers navigating this rapidly evolving field in 2026.
Frequently Asked Questions
What is the difference between mazdutide, survodutide, and cagrilintide?
Mazdutide and survodutide are both dual GLP-1/glucagon agonists (similar mechanism). Cagrilintide is an amylin analog (completely different mechanism). PSPeptides carries all three.
Which is best: mazdutide, survodutide, or cagrilintide?
Depends on research question. For glucagon-mediated fat oxidation: mazdutide or survodutide. For amylin pathway research: cagrilintide. For maximum weight loss: retatrutide (28.3%, triple agonist).
Does PSPeptides sell mazdutide and survodutide?
Yes. Both available at 99%+ independently verified purity. US manufactured, free shipping, same-day processing. Plus cagrilintide and retatrutide for complete metabolic research.
How does mazdutide compare to retatrutide?
Retatrutide activates 3 receptors (GIP+GLP-1+glucagon) vs mazdutide’s 2 (GLP-1+glucagon). Retatrutide produced 28.3% Phase 3 weight loss. Both available at PSPeptides.
All PSPeptides products are sold exclusively for research and laboratory use.